Cerivastatin inhibits inducible NO synthase and ameliorates end-organ damage in rats with high human renin hypertension.

被引:0
|
作者
Park, JK
Muller, DN
Mervaala, EMA
Schmidt, F
Bieringer, M
Schunck, WH
Ganten, D
Haller, H
Luft, FC
机构
[1] Franz Volhard Clin, Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:701 / 701
页数:1
相关论文
共 49 条
  • [1] Cerivastatin inhibits inducible NO synthase and ameliorates end-organ damage in rats with high human hypertension
    Park, JK
    Muller, DN
    Mervaala, EMA
    Schmidt, F
    Bieringer, M
    Schunk, WH
    Ganten, D
    Haller, H
    Luft, FC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 271A - 271A
  • [2] Cerivastatin inhibits inducible NO synthase and ameliorates end-organ damage in rats with high human hypertension
    Park, JK
    Muller, DN
    Mervaala, EMA
    Schmidt, F
    Bieringer, M
    Schunck, WH
    Ganten, D
    Haller, H
    Luft, FC
    HYPERTENSION, 1999, 34 (02) : 344 - 344
  • [3] Cerivastatin inhibits inflammatory mechanisms and ameliorates end-organ damage via inhibition of the MAP kinase pathway and NFκB activation
    Park, JK
    Muller, DN
    Mervaala, EMA
    Schmidt, F
    Bieringer, M
    Schunck, WH
    Ganten, D
    Luft, FC
    Haller, H
    JOURNAL OF HYPERTENSION, 2000, 18 : S132 - S132
  • [4] Inhibition of aldosterone synthesis attenuates development of hypertension and end-organ damage in a high-renin model of hypertension
    Casadas, Virginia
    Schinke-Braun, Martina
    Markovits, Judit
    Zhou, Yinong
    Hu, Chii-Whei
    Nie, Qing
    Brown, Jeffrey
    Pomposiello, Silvia
    HYPERTENSION, 2007, 50 (04) : E87 - E87
  • [5] Inhibition of NF-kB protects against end-organ damage in rats with human renin and angiotensinogen genes
    Dechend, R
    Mueller, DN
    Mervaala, E
    Park, JK
    Schmidt, F
    Theuer, J
    Breu, V
    Haller, H
    Gulba, DC
    Luft, FC
    CIRCULATION, 2000, 102 (18) : 9 - 9
  • [6] Aldosterone synthase inhibitor FAD286 ameliorates angiotensin II-induced end-organ damage
    Fiebeler, A
    Nussberger, J
    Shagdarsuren, E
    Dechend, R
    Rong, S
    Al-Saadi, N
    Gapelyuk, A
    Schirdewan, A
    Wellner, M
    Jeng, A
    Webb, R
    Luft, FC
    Mueller, D
    CIRCULATION, 2004, 110 (17) : 101 - 101
  • [7] Aldosterone synthase inhibitor FAD286 ameliorates angiotensin II-induced end-organ damage
    Fiebeler, A
    Shagdarsuren, E
    Rong, S
    Al-Saadi, N
    Gapelyuk, A
    Schirdewan, A
    Dechend, R
    Wellner, M
    Jeng, AY
    Webb, RL
    Luft, FC
    Muller, DN
    HYPERTENSION, 2004, 44 (04) : 514 - 515
  • [8] Possible involvement of the renin-angiotensin system in adipose tissue in the aggravation of end-organ damage in severe hypertension
    Takemori, K.
    Masuno, K.
    Inoue, T.
    Ito, H.
    JOURNAL OF HYPERTENSION, 2008, 26 : S229 - S229
  • [9] Nitric oxide synthase activity and renal injury in hypertensive SHR and dahl salt sensitive rats: The link between nitric oxide and end-organ disease in hypertension.
    Hayakawa, H
    Raij, L
    HYPERTENSION, 1997, 30 (03) : P44 - P44
  • [10] High Prevalence of Hypertension and End-Organ Damage Late After Coarctation Repair in Normal Arches
    Lee, Melissa G. Y.
    Allen, Sarah L.
    Kawasaki, Ryo
    Kotevski, Aneta
    Koleff, Jane
    Kowalski, Remi
    Cheung, Michael M. H.
    Konstantinov, Igor E.
    Brizard, Christian P.
    d'Udekem, Yves
    ANNALS OF THORACIC SURGERY, 2015, 100 (02): : 647 - 653